News

The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.
Despite the sector’s unusually good understanding of the humanity behind business, many firms still behave like marketing, ...
Becton Dickinson (BDX) announced the first pharma-sponsored combination product clinical trial using the BD Libertas Wearable Injector for ...
Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...
Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...
Medical analysis equipment maker Waters is combining with a unit of Becton Dickinson in a complex spin-merge. At a discount ...
BD has picked a new executive to lead its planned connected care segment, as the company nears the conclusion of its ...
The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading ...